- Home
- KPLT vs XBIT Comparison
KPLT vs XBIT Comparison
Compare KPLT & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- XBIT
- Stock Information
- Founded
- KPLT 2012
- XBIT 2005
- Country
- KPLT United States
- XBIT United States
- Employees
- KPLT N/A
- XBIT N/A
- Industry
- KPLT Diversified Commercial Services
- XBIT Pharmaceuticals and Biotechnology
- Sector
- KPLT Consumer Discretionary
- XBIT Health Care
- Exchange
- KPLT Nasdaq
- XBIT Nasdaq
- Market Cap
- KPLT 79.1M
- XBIT 82.3M
- IPO Year
- KPLT N/A
- XBIT 2015
- Fundamental
- Price
- KPLT $14.66
- XBIT $2.69
- Analyst Decision
- KPLT Hold
- XBIT
- Analyst Count
- KPLT 1
- XBIT 0
- Target Price
- KPLT $10.00
- XBIT N/A
- AVG Volume (30 Days)
- KPLT 113.2K
- XBIT 60.0K
- Earning Date
- KPLT 11-05-2025
- XBIT 11-12-2025
- Dividend Yield
- KPLT N/A
- XBIT N/A
- EPS Growth
- KPLT N/A
- XBIT N/A
- EPS
- KPLT N/A
- XBIT N/A
- Revenue
- KPLT $267,101,999.00
- XBIT N/A
- Revenue This Year
- KPLT $22.88
- XBIT N/A
- Revenue Next Year
- KPLT $10.98
- XBIT N/A
- P/E Ratio
- KPLT N/A
- XBIT N/A
- Revenue Growth
- KPLT 13.04
- XBIT N/A
- 52 Week Low
- KPLT $5.08
- XBIT $2.50
- 52 Week High
- KPLT $24.34
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- KPLT 43.78
- XBIT 43.71
- Support Level
- KPLT $13.18
- XBIT $2.62
- Resistance Level
- KPLT $14.86
- XBIT $2.72
- Average True Range (ATR)
- KPLT 1.64
- XBIT 0.12
- MACD
- KPLT -0.55
- XBIT 0.00
- Stochastic Oscillator
- KPLT 33.04
- XBIT 22.08
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.